British Artificial Intelligence will soon run Clinical Trials

BenevolentAI is a London start-up that specializes in artificial intelligence (AI); its BenevolentBio division, formerly Stratified Medical, applies AI to human health and biotech. Its baby is a technology that could speed up late-stage development of drugs and provide richer clinical data. Now, it will test it using clinical stage drug candidates licensed from Janssen. Although there are no details on the particulars of the agreement, BenevolentAI is confident that it can accelerate clinical development and begin Phase IIb trials in mid-2017. If everything works out well, the company will have exclusive rights to develop, manufacture and commercialize these candidates.